Cost Effectiveness of Pembrolizumab and Ipilimumab in Advanced Melanoma
May 1, 2016, 00:00 AM
10.1016/j.jval.2016.03.1585
https://www.valueinhealthjournal.com/article/S1098-3015(16)01653-3/fulltext
Section Title :
Cancer - Cost Studies
Section Order :
301
First Page :
A149
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01653-3&doi=10.1016/j.jval.2016.03.1585